Clinical Trial Update: Safety and Efficacy of AGN 210669 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on the safety and efficacy of AGN 210669 Ophthalmic Solution in patients with ocular hypertension or primary open-angle glauc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• AGN-210669 ophthalmic solution

Snippet

Sponsor: Allergan | Conditions: Ocular Hypertension, Glaucoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-10-18